Patients with head and neck cancer who attended a survivorship clinic before completing RT were more likely to complete treatment on schedule and had better 3-year DFS than those who did not attend.

Adding irinotecan to adjuvant oxaliplatin-based chemotherapy does not improve 3-year disease-free survival in patients with ...

As I’ve noted, the topic of GLP-1 use and its very favorable impact on health is well established, including in the suggestion that risk for cancer will be decreased. This particular analysis, which ...

In the head-to-head TRANSCEND-T2D-2 trial, participants with type 2 diabetes (T2D) lost more than twice as much weight with retatrutide as with Ozempic (semaglutide) and had a greater reduction in A1c ...

In a phase 2b trial, naronapride, an investigational dual-action prokinetic, administered at 20 or 40 mg three times daily for 12 weeks led to significantly greater improvement in core symptoms than ...